ardeparinhttp://www.unboundmedicine.com/medline/ebm/research/ardeparinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer.http://www.unboundmedicine.com/medline/ebm/record/17710191/full_citation/Evaluation_of_the_Oral_Bioavailability_of_Low_Molecular_Weight_Heparin_Formulated_With_Glycyrrhetinic_Acid_as_Permeation_Enhancer_Motlekar NA, Srivenugopal KS, Wachtel MS, et al. 
Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer. [JOURNAL ARTICLE]
Drug Dev Res 2006 Feb; 67(2):166-174.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.http://www.unboundmedicine.com/medline/ebm/record/16882552/full_citation/Zonula_occludens_toxin_synthetic_peptide_derivative_AT1002_enhances_in_vitro_and_in_vivo_intestinal_absorption_of_low_molecular_weight_heparin_Motlekar NA, Fasano A, Wachtel MS, et al. 
Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin. [Journal Article]
J Drug Target 2006 Jun; 14(5):321-9.
Abstract | Full CitationModulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation.http://www.unboundmedicine.com/medline/ebm/record/16640827/full_citation/Modulation_of_gastrointestinal_permeability_of_low_molecular_weight_heparin_by_L_arginine:_in_vivo_and_in_vitro_evaluation_Motlekar NA, Srivenugopal KS, Wachtel MS, et al. 
Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation. [Journal Article]
J Pharm Pharmacol 2006 May; 58(5):591-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels.http://www.unboundmedicine.com/medline/ebm/record/16390818/full_citation/Oral_delivery_of_low_molecular_weight_heparin_using_sodium_caprate_as_absorption_enhancer_reaches_therapeutic_levels_Motlekar NA, Srivenugopal KS, Wachtel MS, et al. 
Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels. [Journal Article]
J Drug Target 2005 Dec; 13(10):573-83.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Pharmacologic profile of certoparin.http://www.unboundmedicine.com/medline/ebm/record/15992081/full_citation/Pharmacologic_profile_of_certoparin_Jeske W, Wolf H, Ahsan A, et al. 
Pharmacologic profile of certoparin. [Journal Article]
Expert Opin Investig Drugs 1999 Mar; 8(3):315-27.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Enhanced sensitivity electrochemical assay of low-molecular-weight heparins using rotating polyion-sensitive membrane electrodes.http://www.unboundmedicine.com/medline/ebm/record/12879195/full_citation/Enhanced_sensitivity_electrochemical_assay_of_low_molecular_weight_heparins_using_rotating_polyion_sensitive_membrane_electrodes_Qin W, Zhang W, Xiao KP, et al. 
Enhanced sensitivity electrochemical assay of low-molecular-weight heparins using rotating polyion-sensitive membrane electrodes. [Journal Article]
Anal Bioanal Chem 2003 Nov; 377(5):929-36.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.http://www.unboundmedicine.com/medline/ebm/record/12460291/full_citation/Serious_adverse_vascular_events_associated_with_perioperative_interruption_of_antiplatelet_and_anticoagulant_therapy_Alam M, Goldberg LH 
Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. [Case Reports, Journal Article]
Dermatol Surg 2002 Nov; 28(11):992-8; discussion 998.
Abstract | Full Citation | Publisher Full Text | Find Related Articles The low molecular weight heparin, tinzaparin, in thrombosis and beyond.http://www.unboundmedicine.com/medline/ebm/record/12397367/full_citation/The_low_molecular_weight_heparin_tinzaparin_in_thrombosis_and_beyond_Mousa SA 
The low molecular weight heparin, tinzaparin, in thrombosis and beyond. [Journal Article, Review]
Cardiovasc Drug Rev 2002; 20(3):199-216.
Abstract | Full Citation | Find Related Articles Therapeutic equivalency of low-molecular-weight heparins.http://www.unboundmedicine.com/medline/ebm/record/12022908/full_citation/Therapeutic_equivalency_of_low_molecular_weight_heparins_McCart GM, Kayser SR 
Therapeutic equivalency of low-molecular-weight heparins. [Journal Article, Meta-Analysis, Review]
Ann Pharmacother 2002 Jun; 36(6):1042-57.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Ardeparin and danaparoid.http://www.unboundmedicine.com/medline/ebm/record/11998151/full_citation/Ardeparin_and_danaparoid_Ardeparin and danaparoid. [Journal Article, Review]
Dimens Crit Care Nurs 2000 Jul-Aug; 19(4):13-4.
Full Citation | Publisher Full Text | Find Related Articles